Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | BriaCell Therapeutics Corp.: BriaCell Announces Proposed Effective Date of Share Consolidation | 43 | GlobeNewswire (Europe) | PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology... ► Artikel lesen | |
Fr | Palisade Bio, Inc.: Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 40 | GlobeNewswire (Europe) | Carlsbad, CA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade", "Palisade Bio", or the "Company"), a clinical-stage biopharmaceutical company focused on developing... ► Artikel lesen | |
Fr | Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 12 | GlobeNewswire (Europe) | LAKE FOREST, Ill., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering... ► Artikel lesen | |
Fr | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 11 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address... ► Artikel lesen | |
Fr | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 11 | GlobeNewswire (Europe) | SAN FRANCISCO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development... ► Artikel lesen | |
Fr | Creative Realities Announces Departure of Will Logan, Chief Financial Officer | 47 | GlobeNewswire (Europe) | LOUISVILLE, Ky., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (NASDAQ: CREX) ("CRI" or the "Company"), a leading provider of digital signage and media solutions, today announced that... ► Artikel lesen | |
Fr | TeraWulf Inc.: TeraWulf Announces December 2024 Production and Operations Update | 34 | GlobeNewswire (Europe) | Secured high-performance computing (HPC) data center leases with Core42 for more than 70 MW of digital infrastructure, representing total revenue of more than $1 billion over initial 10-year term... ► Artikel lesen | |
Fr | Procaps Group, S.A.: Procaps Group Receives Additional Delinquency Letter | 92 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
Fr | Tandy Leather Factory, Inc.: Tandy Leather Factory Appoints new CEO; Announces Board Changes | 66 | GlobeNewswire (Europe) | FORT WORTH, Texas, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Tandy Leather Factory, Inc. (the "Company", Nasdaq: TLF) today announced it has appointed Johan Hedberg as its new Chief Executive Officer and... ► Artikel lesen | |
Fr | INLIF LIMITED Announces Closing of US$8 Million Initial Public Offering | 24 | GlobeNewswire (Europe) | Quanzhou, China, Jan. 03, 2025 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding... ► Artikel lesen | |
Fr | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 11 | GlobeNewswire (Europe) | BOSTON, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on December 31,... ► Artikel lesen | |
Fr | Fate Therapeutics, Inc.: Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | 19 | GlobeNewswire (Europe) | SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent... ► Artikel lesen | |
Fr | Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | 11 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 31, 2024 it granted stock options to purchase an aggregate... ► Artikel lesen | |
Fr | Sono Group N.V. Announces Reverse Share Split to Be Implemented January 6, 2025, the Signing of SPA for a new $5 million Debenture, and the Signing of an Exchange Agreement for the Exchange of All Its Debt to Equity | 25 | GlobeNewswire (Europe) | Munich, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as "Sono" or the "Company", parent company to Sono Motors GmbH or "Sono... ► Artikel lesen | |
Fr | Trust Stamp Previews Strategic Announcements | 34 | GlobeNewswire (Europe) | Atlanta, GA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Gareth N. Genner, CEO of Trust Stamp, announced, "As our shareholders and observers know, our reverse split will be effective for trading on January... ► Artikel lesen | |
Fr | Boeing Appoints Deasy as Chief Information Officer | 34 | PR Newswire | ARLINGTON, Va., Jan. 3, 2025 /PRNewswire/ -- Boeing [NYSE: BA] today announced Dana Deasy as the company's new chief information digital officer and senior vice... ► Artikel lesen | |
Fr | CNO Financial Group Names Joel Koehneman as Chief Accounting Officer | 30 | PR Newswire | CARMEL, Ind., Jan. 3, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE: CNO) has named Joel Koehneman as Chief Accounting Officer, effective January 21, 2025. He will report to Chief... ► Artikel lesen | |
Fr | FCA US LLC: FCA US Reports Fourth-quarter and Full-year 2024 Sales Results | 53 | PR Newswire | AUBURN HILLS, Mich., Jan. 3, 2025 /PRNewswire/ --
Company's U.S. Q4 2024 retail sales increased 1% versus same period last year
Company's H2 2024 U.S. retail... ► Artikel lesen | |
Fr | Syndax Pharmaceuticals, Inc.: Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 12 | PR Newswire | WALTHAM, Mass., Jan. 3, 2025 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline... ► Artikel lesen | |
Fr | Insmed Incorporated: Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 11 | PR Newswire | BRIDGEWATER, N.J., Jan. 3, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first-... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 445 |
TESLA | 417 |
BAYER | 336 |
TUI | 215 |
NEL | 210 |
EVOTEC | 205 |
BYD | 202 |
PLUG POWER | 181 |
BASF | 171 |
D-WAVE QUANTUM | 170 |
PALANTIR TECHNOLOGIES | 150 |
COMMERZBANK | 149 |
RWE | 145 |
LILIUM | 138 |
MICROSTRATEGY | 133 |
CUREVAC | 131 |
SUPER MICRO COMPUTER | 128 |
NOVO NORDISK | 127 |
RHEINMETALL | 119 |
XIAOMI | 119 |
VERBIO | 115 |
MICROSOFT | 113 |
VOLKSWAGEN | 112 |
DEUTSCHE TELEKOM | 111 |
DEUTSCHE BANK | 110 |